← Open Payments lookup

PUTAO CEN: Open Payments

NPI 1891947735 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$146,574 in 101 payments from 13 companies in 2025. Trend: 2023 $145,897 · 2024 $128,897 · 2025 $146,574

Speaker / faculty: $102,828Speaker / faculty: $27,650Travel & lodging: $8,047Consulting: $5,555Food & beverage: $2,494
CompanyPaymentsAmount
Astellas Pharma US Inc30$50,963
TAIHO ONCOLOGY, INC.22$43,998
Eisai Inc.19$32,716
Merck Sharp & Dohme LLC8$12,795
Ipsen Biopharmaceuticals, Inc2$2,891
AstraZeneca Pharmaceuticals LP5$2,550
Tempus AI, Inc3$201
E.R. Squibb & Sons, L.L.C.2$143
Immunocore Limited1$121
PFIZER INC.4$90

Products named: LONSURF, Vyloy, Lenvima, Padcev, KEYTRUDA, WELIREG, Onivyde, IMFINZI.

Industry payments across TX — which companies pay providers there.